celastrol has been researched along with Cyst in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, MY; Chen, KH; Chen, TD; Chen, YC; Hsieh, CY; Hsu, HH; Hung, CC; Lin, CY; Tian, YC; Yang, CW; Yang, HY | 1 |
| Bange, H; Booij, TH; Dauwerse, JG; Fokkelman, M; Leonhard, WN; Peters, DJM; Plugge, AJ; Price, LS; van de Water, B; van Westen, GJP; Veraar, KAM; Yan, K | 1 |
2 other study(ies) available for celastrol and Cyst
| Article | Year |
|---|---|
Effect of celastrol on the progression of polycystic kidney disease in a Pkd1-deficient mouse model.
Topics: Animals; Cell Proliferation; Cysts; Disease Progression; Female; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentacyclic Triterpenes; Polycystic Kidney, Autosomal Dominant; Triterpenes; TRPP Cation Channels | 2018 |
In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease.
Topics: Animals; Cysts; Drug Evaluation, Preclinical; Kidney Function Tests; Mice; Pentacyclic Triterpenes; Phenotype; Polycystic Kidney Diseases; Signal Transduction; Small Molecule Libraries | 2020 |